ARR vs GTY

The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score, raising transparency concerns. Despite a high dividend yield of 15.62%, the unsustainable payout ratio of 1515.79% and deteriorating earnings (YoY EPS decline of 28.0%) signal severe dividend risk. Valuation metrics are mixed: while the P/B of 0.97 suggests near-book value, the sky-high P/E of 96.63 and negative earnings surprises over the last four quarters imply overvaluation relative to performance. Insider selling, weakening profitability trends, and aggressive leverage (Debt/Equity: 7.81) further undermine confidence in the current price level.

GTY presents a stable financial profile with a Piotroski F-Score of 4/9, indicating a stable but not strong health baseline. The stock is currently priced at $33.30, sitting between its conservative Graham Number ($24.84) and its growth-based Intrinsic Value ($45.13). While the company exhibits impressive earnings growth (33.3% YoY) and superior debt management compared to sector peers, the dividend payout ratio of 124.84% is a significant sustainability concern. Technical trends remain heavily bearish, offsetting the fundamental strengths of high profit margins and consistent earnings beats.